Terms: = Kidney tumors AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Diagnosis
53 results:
1. The Prevalence and Radiologic Features of Renal Cancers Associated with
Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
[TBL] [Abstract] [Full Text] [Related]
2. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract] [Full Text] [Related]
3. Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma.
Sun X; Wang G; Huang Z; Li P; Yang B; Wang T; Li J
Urol Int; 2023; 107(8):819-822. PubMed ID: 37393904
[TBL] [Abstract] [Full Text] [Related]
4. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
5. kidney tumors associated with germline mutations of FH and sdhb show a CpG island methylator phenotype (CIMP).
Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.
Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M
Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930
[TBL] [Abstract] [Full Text] [Related]
7. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
8. [Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].
Zhang HZ; Xia QY; Yin XG; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):437-443. PubMed ID: 35511640
[No Abstract] [Full Text] [Related]
9. Brain Metastases among Cancer Patients Diagnosed from 2010-2017 in Canada: Incidence Proportion at diagnosis and Estimated Lifetime Incidence.
Liu JL; Walker EV; Paudel YR; Davis FG; Yuan Y
Curr Oncol; 2022 Mar; 29(3):2091-2105. PubMed ID: 35323369
[TBL] [Abstract] [Full Text] [Related]
10. Renal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases.
Denize T; Massa S; Valent A; Militti L; Bertolotti A; Barisella M; Rioux-Leclercq N; Malouf GG; Spreafico F; Verschuur A; van der Beek J; Tytgat L; van den Heuvel-Eibrink MM; Vujanic G; Collini P; Coulomb A
Histopathology; 2022 May; 80(6):928-945. PubMed ID: 35238063
[TBL] [Abstract] [Full Text] [Related]
11. [Succinate dehydrogenase-deficient renal cell carcinoma:a clinicopathological, ultrastructural and molecular analysis].
Wang XT; Wang X; Zhang RS; Cheng K; Xia QY; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):12-16. PubMed ID: 34979747
[No Abstract] [Full Text] [Related]
12. Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments.
Agaimy A; Hartmann A; Trpkov K; Hes O
Semin Diagn Pathol; 2021 Nov; 38(6):152-162. PubMed ID: 34579992
[TBL] [Abstract] [Full Text] [Related]
13. sdhC phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
[TBL] [Abstract] [Full Text] [Related]
14. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
Morini A; Drossart T; Timsit MO; Sibony M; Vasiliu V; Gimenez-Roqueplo AP; Favier J; Badoual C; Mejean A; Burnichon N; Verkarre V
Mod Pathol; 2022 Mar; 35(3):352-360. PubMed ID: 34531523
[TBL] [Abstract] [Full Text] [Related]
15. Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Takagi T; Yoshida K; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Ishida H; Tanabe K
Jpn J Clin Oncol; 2021 Dec; 51(12):1744-1750. PubMed ID: 34487184
[TBL] [Abstract] [Full Text] [Related]
16. [Oncocytic tumours of the kidney-new differential diagnoses].
Polifka I; Ohashi R; Moch H
Pathologe; 2021 Nov; 42(6):551-559. PubMed ID: 34468818
[TBL] [Abstract] [Full Text] [Related]
17. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
[TBL] [Abstract] [Full Text] [Related]
18. Immunoexpression of sdhb, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study.
Karatay H; Ozluk Y; Dogan MA; Erdem S; Kilicaslan I
Ann Diagn Pathol; 2021 Oct; 54():151788. PubMed ID: 34246177
[TBL] [Abstract] [Full Text] [Related]
19. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
20. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract] [Full Text] [Related]
[Next]
